Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14422
Articles
Company
Drug
Fujian Cosunter Receives Multiple Patents for Cancer and Hepatitis Drugs
January 31, 2025
Company
Drug
Sinocelltech’s SCTV01E Vaccine Receives NMPA Approval for Phase II Study
January 31, 2025
Company
Drug
3SBio’s Thrombopoietin Study in Pediatric ITP Reaches Primary Endpoint
January 31, 2025
Company
Deals
Zenas BioPharma Completes $118M Series B Financing to Advance Obexelimab
January 31, 2025
Company
Drug
LianBio Initiates Phase I Study of SHP2 Inhibitor BBP-398 in China
January 31, 2025
Company
Deals
Innovex Medical Files for IPO in Hong Kong to Boost Product Development
January 31, 2025
Company
Drug
NMPA Conditionally Approves Yingli Pharma’s Linperlisib for Lymphoma
January 31, 2025
Company
Drug
Ascentage Pharma Gains CDE Approval for Phase I Study of APG-5918
January 31, 2025
Policy / Regulatory
China Releases 14th Five-Year Plan for National Health Informatization
January 31, 2025
Company
Zai Lab Reports 33% YOY Revenue Growth in Q3 2022
January 31, 2025
Company
Deals
GSK Partners with CASPC to Advance HIV Sustained Care Advocacy in China
January 31, 2025
Company
Drug
3SBio Receives NMPA Review for Pediatric ITP Thrombopoietin Filing
January 31, 2025
1
2
…
1,096
1,097
1,098
1,099
1,100
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
